Customer reported via phone call that they were hospitalized due to high blood glucose level and slight kidney failure on (b)(6) 2022.Customer's blood glucose value was 586 mg/dl at the time of the incident.Customer's current blood glucose level was 286 mg/dl.The customer was assisted with troubleshooting for high blood glucose.The customer stated that the symptoms related to high blood glucose such as feeling sick or unwell, headache, extremity pain or cramps, increased thirst, nausea, vomiting and abdominal pain.The customer was treated with manual injection and the insulin pump.Customer had been using insulin pump system within 48 hours of reported high blood glucose event.Customer stated that the auto mode feature was active at time of high blood glucose event.Customer did allege insulin pump was under delivering.Customer reported cannula was kinned.No further patient complications were reported.The device will not be returned for analysis.
|
This mdr related to the puerto rico manufacturing site has been assigned a medwatch number from the medtronic minimed northridge site, per variance 5.Medtronic, inc.(medtronic) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information in the time allotted and has provided as much information as is available to the company as of the submission date this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employees caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any "defects" or has "malfunctioned".These words are included in the fda 3500a form and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.Medtronic objects to the use of these words and others like it because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.The information that provided with the initial report was incorrect.The correct information has been included with this report in b3 section.
|